Bold claim: Kennedy’s promises to steer health policy as health secretary haven’t held up, and the gap between his pledges and real actions has sparked widespread debate. And this is the part most people miss: the consequences of personnel decisions at a federal agency can shift public health directions in lasting ways. Here’s a clear, beginner-friendly rewrite that preserves all key details while clarifying what happened, why it matters, and what it means going forward.
Robert F. Kennedy Jr. was sworn in as the head of the Department of Health and Human Services (HHS) in the Oval Office on February 13, 2025. A year into his tenure, Kennedy has not fulfilled many of the assurances he offered during his confirmation process about vaccine funding and vaccine-policy decisions.
During Kennedy’s confirmation, he faced a narrow Senate vote and provided public and private guarantees about how he would handle vaccines, including funding and recommendations. He repeatedly stated that he supported vaccines and the childhood vaccination schedule, noting that all of his own children were vaccinated.
However, prominent moments of contention emerged in the confirmation hearings. Senator Elizabeth Warren questioned Kennedy’s financial ties to lawsuits against vaccine manufacturers and suggested potential conflicts of interest should policy change in ways that could affect vaccine access and funding. Warren warned that Kennedy could leverage new policies for profit, implying that vaccine access could be curtailed while Kennedy benefited financially. Kennedy responded by affirming his support for vaccines and the childhood schedule.
Senator Bill Cassidy, a Republican and the chair of the Senate committee overseeing health policy, pressed Kennedy on whether existing CDC vaccine recommendations would be maintained if confirmed. Cassidy stated that Kennedy had pledged to keep the Advisory Committee on Immunization Practices (ACIP) recommendations unchanged. Cassidy’s line of questioning reflected a strong pro-vaccine stance and concern about how Kennedy’s past positions might influence future guidance.
After Kennedy was confirmed, substantial changes followed. He removed the existing ACIP members and appointed new members, including individuals who share skepticism about certain vaccines. This reshaped the panel’s output, and vaccine guidance shifted accordingly.
In the months that followed, the CDC adjusted its universal vaccination recommendations. The agency scaled back guidance for several vaccines, advising protection primarily for high-risk children or after discussions between doctors and parents. This shift aligned with a White House memorandum directing a reevaluation of the schedule.
HHS spokesperson Andrew Nixon defended Kennedy’s actions, saying the secretary was honoring his commitments to Cassidy and continuing dialogue with the chairman. Nixon claimed Kennedy remained engaged with Cassidy and complied with recommendations for agency roles and language on the CDC website.
Questions have persisted about whether Kennedy has truly kept the commitments he made to Cassidy since becoming secretary. Cassidy’s office has repeatedly declined to answer whether Kennedy has violated those commitments.
Funding for vaccination programs also faced changes. Shortly after Kennedy assumed leadership, the CDC pulled back approximately $11 billion in COVID-era grants used by local health departments for vaccination programs and other initiatives. Kennedy had been asked in hearings whether he would prevent any reduction or diversion of congressional funding for vaccination programs, and he answered affirmatively. A federal judge later ordered HHS to distribute the money.
Separately, the National Institutes of Health halted dozens of vaccine-hesitancy research grants, while Kennedy ordered the cancellation of roughly half a billion dollars’ worth of mRNA vaccine research in August.
A controversial point concerns vaccine safety statements. Cassidy said he had secured Kennedy’s commitment that the CDC’s website would not remove statements asserting that vaccines do not cause autism. Kennedy reportedly upheld the commitment on the surface, as the CDC site continued to include language stating that vaccines do not cause autism. Yet, later updates introduced wording suggesting that the claim “vaccines do not cause autism” is not an evidence-based claim because studies have not ruled out potential links. This framing has been criticized as misleading, given decades of research showing no credible link between vaccines and autism.
The history around this issue includes a highly publicized but subsequently retracted 1998 study linking a measles, mumps, and rubella (MMR) vaccine to autism. The study was withdrawn for fraud, though its impact on vaccination rates lingered for years before the retraction was fully acknowledged.
For context, KFF Health News is a national newsroom focused on health journalism and is part of the broader KFF organization. The coverage above reflects ongoing reporting on vaccine policy, funding, and public communication in the federal health system.
If you’d like, I can add a brief explainer of how ACIP works and why changes to its composition can influence immunization guidelines, with simple examples to help beginners understand the process.
